Biosimilars Price Competition: Impact on U.S. P...

By João L. Carapinha

May 22, 2025

The study "The Price Effects of Biosimilars in the United States" evaluates how biosimilars price competition impacts pricing in the U.S. pharmaceutical market. It focuses on Medicare Part B average sales price (ASP) dynamics from 2015 to 2023 acr...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
Drug Pricing Analysis: ICER’s Launch Price and Access Report Aims to En...
Trends in Anticancer Drug Pricing: Analyzing Medicare Launch Prices and Impac...
Publication Delays Impact Careers of Early-Career Researchers
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control
FDA AI Drug Approval
HCV Treatment Advancements: Atea Pharmaceuticals KOL Panel
Wegovy CVS Deal: Hybrid Market Access Strategy Insights
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure
Promising Results for Peanut Oral Immunotherapy